Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
42
KNEVF Quote, Financials, Valuation and Earnings
Last price:
$7.53
Seasonality move
:
2.24%
Day range:
$7.53 - $7.53
52-week range:
$6.57 - $9.72
Dividend yield:
0%
P/E ratio:
101.92x
P/S ratio:
2,050.54x
P/B ratio:
0.55x
Volume:
--
Avg. volume:
95
1-year change:
-7.27%
Market cap:
$2.1B
Revenue:
$1M
EPS (TTM):
-$1.16
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $197.9M | $350.7M | $89.2M | $4M | $1M | |
| Revenue Growth (YoY) | 7.1% | 77.2% | -74.56% | -95.55% | -74.33% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -$4.6M | $32.9M | $37.2M | -- | |
| Operating Expenses | -$1.7B | $1.9B | $461.9M | $261.1M | $464.3M | |
| Operating Income | $1.7B | -$1.9B | -$461.9M | -$261.1M | -$464.3M | |
| Net Interest Expenses | $6.2M | $6.8M | $8.5M | $6.1M | $9.7M | |
| EBT. Incl. Unusual Items | $1.7B | -$1.9B | -$448.9M | -$248M | -$432.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $582.4K | -- | -- | $94.6K | -$91M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.7B | -$1.9B | -$448.9M | -$248.1M | -$341.2M | |
| Basic EPS (Cont. Ops) | $6.19 | -$6.90 | -$1.60 | -$0.90 | -$1.23 | |
| Diluted EPS (Cont. Ops) | $6.19 | -$6.90 | -$1.60 | -$0.90 | -$1.23 | |
| Weighted Average Basic Share | $278.2M | $279.5M | $281M | $277M | $277M | |
| Weighted Average Diluted Share | $278.2M | $279.5M | $281M | $277M | $277M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.7B | -$1.9B | -$461.9M | -$261.1M | -$464.3M | |
| Revenue (Reported) | $197.9M | $350.7M | $89.2M | $4M | $1M | |
| Operating Income (Reported) | $1.7B | -$1.9B | -$461.9M | -$261.1M | -$464.3M | |
| Operating Income (Adjusted) | $1.7B | -$1.9B | -$461.9M | -$261.1M | -$464.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $64M | $43.3M | $44.2M | $463.8K | $318.9K | |
| Revenue Growth (YoY) | -53.15% | -32.38% | 2.27% | -98.95% | -31.24% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $408M | $477.5M | $259.3M | -$159.6M | $279.3M | |
| Operating Income | -$408M | -$477.5M | -$259.3M | $159.6M | -$279.3M | |
| Net Interest Expenses | -- | -- | $9.5M | $3.5M | $744.1K | |
| EBT. Incl. Unusual Items | -$390.6M | -$474.1M | -$246.2M | $166.5M | -$273M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $564.2K | -- | -- | $92.8K | -$94.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$391.2M | -$474.1M | -$246.2M | $166.4M | -$178.2M | |
| Basic EPS (Cont. Ops) | -$1.41 | -$1.69 | -$0.87 | $0.60 | -$0.64 | |
| Diluted EPS (Cont. Ops) | -$1.41 | -$1.69 | -$0.87 | $0.60 | -$0.64 | |
| Weighted Average Basic Share | $278.2M | $280.1M | $281.6M | $277M | $277M | |
| Weighted Average Diluted Share | $278.2M | $280.1M | $281.6M | $277M | $277M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$408M | -$477.5M | -$259.3M | $159.6M | -$279.3M | |
| Revenue (Reported) | $64M | $43.3M | $44.2M | $463.8K | $318.9K | |
| Operating Income (Reported) | -$408M | -$477.5M | -$259.3M | $159.6M | -$279.3M | |
| Operating Income (Adjusted) | -$408M | -$477.5M | -$259.3M | $159.6M | -$279.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $198.5M | $356.5M | $89.3M | $4M | $1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$1.8B | $2B | $472.6M | $294.7M | $446.6M | |
| Operating Income | $1.8B | -$2B | -$472.6M | -$294.7M | -$446.6M | |
| Net Interest Expenses | $2.3M | $19.7M | $22.4M | $19.2M | $9.6M | |
| EBT. Incl. Unusual Items | $1.8B | -$1.9B | -$439M | -$251.9M | -$414.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $564.2K | -- | -- | $92.8K | -$94.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.8B | -$1.9B | -$439M | -$252M | -$320M | |
| Basic EPS (Cont. Ops) | $6.43 | -$6.95 | -$1.57 | -$0.91 | -$1.16 | |
| Diluted EPS (Cont. Ops) | $6.43 | -$6.95 | -$1.57 | -$0.91 | -$1.16 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.8B | -$2B | -$472.6M | -$294.7M | -$446.6M | |
| Revenue (Reported) | $198.5M | $356.5M | $89.3M | $4M | $1M | |
| Operating Income (Reported) | $1.8B | -$2B | -$472.6M | -$294.7M | -$446.6M | |
| Operating Income (Adjusted) | $1.8B | -$2B | -$472.6M | -$294.7M | -$446.6M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $356.5M | $89.3M | $4M | $1M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2B | $472.6M | $294.7M | $446.6M | -- | |
| Operating Income | -$2B | -$472.6M | -$294.7M | -$446.6M | -- | |
| Net Interest Expenses | $19.7M | $22.4M | $19.2M | $9.6M | -- | |
| EBT. Incl. Unusual Items | -$1.9B | -$439M | -$251.9M | -$414.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $92.8K | -$94.8M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.9B | -$439M | -$252M | -$320M | -- | |
| Basic EPS (Cont. Ops) | -$6.95 | -$1.57 | -$0.91 | -$1.16 | -- | |
| Diluted EPS (Cont. Ops) | -$6.95 | -$1.57 | -$0.91 | -$1.16 | -- | |
| Weighted Average Basic Share | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| Weighted Average Diluted Share | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$2B | -$472.6M | -$294.7M | -$446.6M | -- | |
| Revenue (Reported) | $356.5M | $89.3M | $4M | $1M | -- | |
| Operating Income (Reported) | -$2B | -$472.6M | -$294.7M | -$446.6M | -- | |
| Operating Income (Adjusted) | -$2B | -$472.6M | -$294.7M | -$446.6M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $1.3B | $1.2B | $1.3B | $1.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.2B | $1.4B | $1.2B | $1.3B | $1.1B | |
| Property Plant And Equipment | $5.7M | $4.5M | $10.6M | $11.8M | $14.3M | |
| Long-Term Investments | $7.5B | $4.2B | $4.1B | $2.6B | $3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $8.7B | $5.5B | $5.3B | $4B | $4.1B | |
| Accounts Payable | $3.6M | $2M | $1.7M | $1.5M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $202M | $37.5M | $86.9M | $171.5M | $163.1M | |
| Long-Term Debt | $384.8M | $334.8M | $346M | $180.3M | $59.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $684.3M | $463M | $531M | $443.9M | $243.5M | |
| Common Stock | $3.1M | $2.7M | $2.8M | $2.5M | $3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $8B | $5.1B | $4.8B | $3.5B | $3.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8B | $5.1B | $4.8B | $3.5B | $3.9B | |
| Total Liabilities and Equity | $8.7B | $5.5B | $5.3B | $4B | $4.1B | |
| Cash and Short Terms | $1.2B | $1.3B | $1.2B | $1.3B | $1.1B | |
| Total Debt | $518.5M | $334.8M | $346M | $316M | $222.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $1.3B | $1.2B | $1.3B | $1.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.2B | $1.4B | $1.2B | $1.3B | $1.1B | |
| Property Plant And Equipment | $5.7M | $4.5M | $10.6M | $11.8M | $14.3M | |
| Long-Term Investments | $7.5B | $4.2B | $4.1B | $2.6B | $3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $8.7B | $5.5B | $5.3B | $4B | $4.1B | |
| Accounts Payable | $3.6M | $2M | $1.7M | $1.5M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $202M | $37.5M | $86.9M | $171.5M | $163.1M | |
| Long-Term Debt | $384.8M | $334.8M | $346M | $180.3M | $59.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $684.3M | $463M | $531M | $443.9M | $243.5M | |
| Common Stock | $3.1M | $2.7M | $2.8M | $2.5M | $3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8B | $5.1B | $4.8B | $3.5B | $3.9B | |
| Total Liabilities and Equity | $8.7B | $5.5B | $5.3B | $4B | $4.1B | |
| Cash and Short Terms | $1.2B | $1.3B | $1.2B | $1.3B | $1.1B | |
| Total Debt | $518.5M | $334.8M | $346M | $316M | $222.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $152.9M | $314.1M | $56.5M | -$20.8M | -$21.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$25M | $136.5M | -$267.5M | $839M | -$270.1M | |
| Dividends Paid (Ex Special Dividend) | $5.1M | -- | -- | $602.5M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $233.7M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$22.2M | -$120.6M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $216.3M | -$119.6M | -- | -$602.5M | -$152.9M | |
| Beginning Cash (CF) | $426.3M | $298.5M | $1B | $1.3B | $40.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $344.2M | $331M | -$211M | $215.7M | -$445M | |
| Ending Cash (CF) | $770.6M | $629.5M | $826M | $1.5B | -$404.7M | |
| Levered Free Cash Flow | $152.9M | $314.1M | $56.5M | -$20.8M | -$21.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $51.1M | $36.8M | $40M | -$7.7M | -$10.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $404.1M | -$239.4M | -$32.7M | -$135.4M | -$2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $590.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $233.7M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$22.2M | -$5.2M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $204.6M | -- | -- | $20.3M | -$1.9M | |
| Beginning Cash (CF) | $426.3M | $298.5M | $1B | $1.3B | $40.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $659.8M | -$202.6M | $7.3M | -$122.8M | -$14.9M | |
| Ending Cash (CF) | $1.1B | $95.9M | $1B | $1.2B | $25.4M | |
| Levered Free Cash Flow | $51.1M | $36.8M | $40M | -$7.7M | -$10.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $151.7M | $319.2M | $56.7M | -$20.6M | -$22.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$40M | $163.8M | -$267.8M | $802.9M | -$281.7M | |
| Dividends Paid (Ex Special Dividend) | $5.2M | -- | -- | $590.9M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $233.7M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$120.6M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $209.8M | -$129.5M | -- | -$590.9M | -$159.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $321.6M | $353.5M | -$211.1M | $191.4M | -$464.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $151.7M | $319.2M | $56.7M | -$20.6M | -$22.9M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $319.2M | $56.7M | -$20.6M | -$22.9M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $163.8M | -$267.8M | $802.9M | -$281.7M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $590.9M | -- | -- | |
| Special Dividend Paid | -- | -- | $2.2M | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$120.6M | -- | -- | -$155.4M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$129.5M | -- | -$590.9M | -$159.6M | -- | |
| Beginning Cash (CF) | $897.9M | $1.5B | $3.5B | $240.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $353.5M | -$211.1M | $191.4M | -$464.1M | -- | |
| Ending Cash (CF) | $1.3B | $1.3B | $3.7B | -$223.8M | -- | |
| Levered Free Cash Flow | $319.2M | $56.7M | -$20.6M | -$22.9M | -- | |
Related Companies
Get KNEVF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KNEVF
Sector
P/E ratio
101.92x
12.49x
PEG ratio
-0.24x
0.32x
P/B ratio
0.55x
1.14x
Price / LTM sales
2,050.54x
1.85x
Growth Metrics
KNEVF
Sector
Revenue growth
-31.24%
5.46%
Earnings growth
-207.07%
10.33%
Revenue (5-year growth)
-64.65%
8.67%
Earnings forecast
--
$0.64
Profitability
KNEVF
Sector
Profitability FY 2025
--
--
Return on invested capital
-7.97%
5.19%
Return on assets
-7.78%
1.03%
Return on equity
-8.47%
9.9%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
Apr
16
Estimated Next Earnings Date
May
5
Balance Sheet
KNEVF
Sector
Total cash
$1.1B
$406.5M
Short term investments
--
$190.5M
Total assets
$4.1B
$3.1B
Long term debt
$222.4M
$55.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
